New study maps lymphoma care gaps in MEA region

NCT ID NCT07065344

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study will look at 500 people with diffuse large B-cell lymphoma (DLBCL) in the Middle East and Africa. Researchers want to understand patient characteristics, current treatment patterns, and how easily patients can access newer therapies like CAR-T cell therapy. The study does not test any new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: This study could help doctors better understand how DLBCL is treated in the Middle East and Africa, and identify barriers to newer therapies.
What could go wrong: This is an observational study, not a treatment trial. It will not test any new drug or directly improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse large B-cell lymphoma hematologic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIFFUSED LARGE B CELL LYMPHOMA HEMATOLOGY

Contacts and locations

Locations

Research Site
NOT_YET_RECRUITING

Al Mansurah, Egypt
Research Site
NOT_YET_RECRUITING

Alexandria, Egypt
Research Site
NOT_YET_RECRUITING

Cairo, Egypt
Research Site
NOT_YET_RECRUITING

Sohag, Egypt
Research Site
NOT_YET_RECRUITING

Tanta, Egypt
Research Site
NOT_YET_RECRUITING

Baghdad, Iraq
Research Site
RECRUITING

Amman, Jordan
Research Site
NOT_YET_RECRUITING

Kuwait City, Kuwait
Research Site
NOT_YET_RECRUITING

Casablanca, Morocco
Research Site
NOT_YET_RECRUITING

Rabat, Morocco
Research Site
RECRUITING

Muscat, Oman
Research Site
RECRUITING

Doha, Qatar
Research Site
RECRUITING

Dammam, Saudi Arabia
Research Site
RECRUITING

Jeddah, Saudi Arabia
Research Site
RECRUITING

Riyadh, Saudi Arabia
Research Site
NOT_YET_RECRUITING

Riyadh, Saudi Arabia
Research Site
RECRUITING

Ankara, Turkey (Türkiye)
Research Site
RECRUITING

Antalya, Turkey (Türkiye)
Research Site
RECRUITING

Istanbul, Turkey (Türkiye)
Research Site
RECRUITING

Izmir, Turkey (Türkiye)
Research Site
RECRUITING

Abu Dhabi, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.